NGMC LUMPKIN LLC — History
CCN 110237 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$27M
Latest Revenue (FY2022)
+58.7%
Revenue CAGR (3yr)
14.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $11M | $22M | $27M | +23.3% | +58.7% |
| Operating Expenses | $15M | $20M | $23M | +13.2% | +25.5% |
| Operating Margin | -36.5% | 7.0% | 14.6% | +109.1% | +0.0% |
| Net Income | $-4M | $2M | $4M | +157.7% | +0.0% |
| Licensed Beds | 24 | 24 | 24 | +0.0% | +0.0% |
| Total Patient Days | 2,440 | 6,099 | 4,994 | -18.1% | +43.1% |
| Medicare Day % | 20% | 24% | 25% | +2.7% | +11.3% |
| Medicaid Day % | 2% | 11% | 6% | -46.4% | +50.6% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +151.9% ($11M → $27M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+58.7%
This Hospital
+7.6%
State Avg
Latest Margin
14.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $35M | 40.2% |
| FY2024 (proj) | $43M | 65.8% |
| FY2025 (proj) | $51M | 91.3% |